Clinical and Genetic Characteristics, Target Therapy Results in Children with Traps Syndrome (on Clinical Surveillance Data)

The complexity of diagnosing and predicting the course of TNF-receptor-associated periodic syndrome TRAPS determines the importance of studying the dependence of clinical manifestations on the variant of genetic mutation and the presence of modifier genes. We observed 5 children with an identified d...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Antsiferova, T. V. Cherkashina, N. G. Wolf, I. Yu. Naumenko, E. A. Anikina, N. G. Kiseleva, N. Yu. Makarevskaya, T. E. Taranushenko, L. N. Antsiferova, E. Yu. Emelyanchik
Format: Article
Language:Russian
Published: IMA PRESS LLC 2021-09-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3064
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The complexity of diagnosing and predicting the course of TNF-receptor-associated periodic syndrome TRAPS determines the importance of studying the dependence of clinical manifestations on the variant of genetic mutation and the presence of modifier genes. We observed 5 children with an identified diagnosis of TRAPS. It was established that the disease onset in most cases is defined as a juvenile arthritis with systemic onset. Genetic variants with the replacement of cysteine residues are associated with an early debut and an aggressive course, the c.362G> A p.R121Q mutation is associated with an erosive damage to the spine. The case of a favorable course of TRAPS in siblings with a newly detected mutation is described. The development of urgent complications of TRAPS was revealed when basic therapy with canakinumab was canceled.
ISSN:1995-4484
1995-4492